CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Return 73.3%
This Quarter Return
+17.65%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$1.6B
AUM Growth
+$135M
Cap. Flow
-$43.7M
Cap. Flow %
-2.73%
Top 10 Hldgs %
60.85%
Holding
38
New
3
Increased
13
Reduced
9
Closed
2

Top Buys

1
ALKS icon
Alkermes
ALKS
$42.7M
2
NRIX icon
Nurix Therapeutics
NRIX
$37.1M
3
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$32.7M
4
CNTA
Centessa Pharmaceuticals
CNTA
$21.6M
5
TIL icon
Instil Bio
TIL
$10.2M

Top Sells

1
NUVL icon
Nuvalent
NUVL
$56M
2
PCVX icon
Vaxcyte
PCVX
$44M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
$30.1M
4
COGT icon
Cogent Biosciences
COGT
$23.7M
5
IMVT icon
Immunovant
IMVT
$19.8M

Sector Composition

1 Healthcare 99.53%
2 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
THRD
26
DELISTED
Third Harmonic Bio
THRD
$18.4M 1.15%
1,360,569
-184,857
-12% -$2.5M
SNDX icon
27
Syndax Pharmaceuticals
SNDX
$1.39B
$17M 1.06%
885,000
+60,000
+7% +$1.16M
APGE icon
28
Apogee Therapeutics
APGE
$2.21B
$17M 1.06%
290,000
– –
ABVX
29
Abivax
ABVX
$6.47B
$14.8M 0.92%
1,284,110
– –
TIL icon
30
Instil Bio
TIL
$205M
$10.2M 0.63%
+150,929
New +$10.2M
NGNE icon
31
Neurogene
NGNE
$280M
$8.39M 0.52%
200,000
– –
PCSC
32
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
$117M
$7.51M 0.47%
750,000
– –
BBOT
33
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$798M
$5.22M 0.33%
500,000
– –
CABA icon
34
Cabaletta Bio
CABA
$141M
$5.19M 0.32%
1,100,000
– –
VTGN icon
35
VistaGen Therapeutics
VTGN
$111M
$4.74M 0.3%
1,575,000
– –
AVTX icon
36
Avalo Therapeutics
AVTX
$134M
$4.59M 0.29%
483,000
+443,000
+1,108% +$4.21M
AUTL
37
Autolus Therapeutics
AUTL
$386M
– –
-1,178,723
Closed -$4.1M
IMVT icon
38
Immunovant
IMVT
$2.81B
– –
-750,990
Closed -$19.8M
1
2